Company intelligence / Profile preview

Couvreur

Brussels, Belgium

Ownership: Private
Development stage: Other

Overview

Laboratoires Couvreur was a prominent Belgian pharmaceutical company specializing in the development and manufacture of over-the-counter (OTC) medicines and healthcare products. The company was best known for its range of cough syrups, analgesics, and digestive health treatments, which became household staples in the Benelux region. Following its acquisition by Omega Pharma, the Couvreur brand and its product portfolio were integrated into a larger consumer healthcare platform. Today, the legacy of the company continues through its established brands, which remain available under the ownership of Perrigo.

Therapeutic areas: GastroenterologyNeurologyPulmonologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Couvreur.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Couvreur.

Explore the full profile